Vorasidenib (AG-881) structure
|
Common Name | Vorasidenib (AG-881) | ||
---|---|---|---|---|
CAS Number | 1644545-52-7 | Molecular Weight | 414.74 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C14H13ClF6N6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Vorasidenib (AG-881)Vorasidenib is a pan isocitrate dehydrogenase (IDH) inhibitor. |
Name | AG881 |
---|---|
Synonym | More Synonyms |
Description | Vorasidenib is a pan isocitrate dehydrogenase (IDH) inhibitor. |
---|---|
Related Catalog | |
Target |
IDH[1] |
In Vitro | Vorasidenib has recently entered phase 1 clinical trials in hematologic (NCT02492737) and solid malignancies (NCT02481154) in patients with either an IDH1 or an IDH2 mutation. Preclinical studies have suggested that Vorasidenib fully penetrates the blood-brain barrier and may be a more effective option for patients with IDH1/2 mutated glioma[1]. |
References |
Molecular Formula | C14H13ClF6N6 |
---|---|
Molecular Weight | 414.74 |
Storage condition | -20℃ |
Vorasidenib |